D
Galapagos NV GLPG
$32.45 $0.6552.06% NASDAQ
Recommendation
Prev Close
$31.79
Volume
31,995
Avg Vol (90D)
351,308
Market Cap
$2.10B
Dividend & Yield
--
52-Week Range
$22.36 - $33.86
P/E (TTM)
--
EPS (TTM)
-$1.41
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Galapagos Creates New Subscription Right Plan
8/7/2025 - Globe Newswire
Galapagos NV (NASDAQ:GLPG) Given Average Recommendation of "Strong Sell" by Brokerages
8/6/2025 - Ticker Report
Galapagos NV Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to GLPG5101 for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma
8/6/2025 - Globe Newswire
2,962 Shares in Galapagos NV (NASDAQ:GLPG) Purchased by Wealthquest Corp
8/2/2025 - Ticker Report
Galapagos NV Reports Strong H1 2025 Results Amid Strategic Transformation
7/24/2025 - TipRanks Financial Blog
Galapagos Appoints New Directors to Strengthen Board
7/23/2025 - TipRanks Financial Blog
Galapagos Bolster Leadership Team with Seasoned Life Sciences Executives to Accelerate Business Transformation
7/23/2025 - Globe Newswire
Galapagos Welcomes Seasoned Pharmaceutical Executives Dawn Svoronos and Jane Griffiths to Its Board of Directors
7/23/2025 - Globe Newswire
Galapagos Reports Half-Year 2025 Financial Results and Provides Second Quarter Business Update
7/23/2025 - Globe Newswire
Galapagos Reaches Analyst Target Price
6/26/2025 - ETF Channel
Wealthquest Corp Invests $74,000 in Galapagos NV (NASDAQ:GLPG)
6/25/2025 - Ticker Report
Notable Two Hundred Day Moving Average Cross - GLPG
6/23/2025 - Market News Video
Galapagos Appoints Aaron Cox as Chief Financial Officer
6/23/2025 - Globe Newswire
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101
6/18/2025 - Globe Newswire
Galapagos Unveils Promising CAR-T Data at EHA 2025
6/13/2025 - TipRanks Financial Blog
Galapagos to Present New ATALANTA-1 CAR-T Data at EHA 2025, Highlighting Low Toxicity and Rapid, Decentralized Delivery of Fresh, Early-Memory-Enriched GLPG5101 in R/R NHL
6/12/2025 - Globe Newswire
Galapagos NV (NASDAQ:GLPG) Given Consensus Rating of "Reduce" by Brokerages
6/12/2025 - MarketBeat
Galapagos NV (NASDAQ:GLPG) Shares Sold by Millennium Management LLC
6/5/2025 - MarketBeat
Wealthedge Investment Advisors LLC Acquires New Holdings in Galapagos NV (NASDAQ:GLPG)
5/30/2025 - MarketBeat
Galapagos Creates New Subscription Right Plan
5/27/2025 - Globe Newswire
Galapagos Reaches Analyst Target Price
5/21/2025 - ETF Channel
Galapagos NV (NASDAQ:GLPG) Position Increased by Tang Capital Management LLC
5/20/2025 - MarketBeat
Galapagos NV (NASDAQ:GLPG) Receives Consensus Recommendation of "Reduce" from Analysts
5/20/2025 - MarketBeat
Galapagos NV (NASDAQ:GLPG) Shares Sold by Suvretta Capital Management LLC
5/19/2025 - MarketBeat
Newtyn Management LLC Sells 230,000 Shares of Galapagos NV (NASDAQ:GLPG)
5/16/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
$4.48B
Total Debt (Q)
$9.92M
Total Liabilities (Q)
$1.38B
Book Value Per Share (Q)
$47.12
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, July 24, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Oct 27 and 31 (est)
Price History
Loading...
Beta
0.66
7-Day Total Return
-1.41%
30-Day Total Return
7.26%
60-Day Total Return
11.11%
90-Day Total Return
31.57%
Year to Date Total Return
16.31%
1-Year Total Return
9.46%
2-Year Total Return
-14.01%
3-Year Total Return
-35.08%
5-Year Total Return
-75.12%
52-week Low
Feb 10, 2025 - $22.36
52-week High
Aug 05, 2025 - $33.86
Valuation
Market Cap
$2.10B - Mid Cap
Enterprise Value
-$1.50B
Price/Sales (TTM)
13.57
Price/Book (Q)
0.67
Dividends and Shares
Shares Outstanding
65.96
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.glpg.com
Phone Number
32 1 534 29 00
Address
Generaal De Wittelaan L11 A3
Mechelen, 2800
Country
Belgium
Year Founded
1999
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667 that has... more
NASDAQ 08/27/2025 10:51AM Eastern Quotes delayed